Bank Of New York Mellon Corp Atara Biotherapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.8 - $5.46 $911,601 - $1.78 Million	325,572 New	325,572 $944 Million
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $910,592 - $1.66 Million	319,506 New	319,506 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $989,693 - $3.03 Million	347,261 Added 117.76%	642,158 $2.43 Million
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $95,535 - $200,440	-20,370 Reduced 6.46%	294,897 $2.3 Million
Q1 2022 May 11, 2022	BUY	$8.44 - $16.89 $50,302 - $100,664	5,960 Added 1.93%	315,267 $2.93 Million

Q4 2021 Feb 11, 2022	BUY	$14.7 - $19.89 $92,257 - $124,829	6,276 Added 2.07%	309,307 $4.88 Million
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $311,560 - $465,131	25,985 Added 9.38%	303,031 $5.42 Million
Q2 2021 Aug 11, 2021	SELL	$12.89 - $16.58 $245,451 - $315,716	-19,042 Reduced 6.43%	277,046 $4.31 Million
Q1 2021 May 13, 2021	SELL	$14.0 - $20.72 $133,350 - $197,358	-9,525 Reduced 3.12%	296,088 $4.25 Million
Q4 2020 Feb 09, 2021	BUY	$12.67 - $26.23 $376,235 - $778,899	29,695 Added 10.76%	305,613 $6 Million
Q3 2020 Nov 12, 2020	BUY	$11.92 - $15.87 $352,688 - $469,561	29,588 Added 12.01%	275,918 $3.58 Million
Q2 2020 Aug 12, 2020	BUY	$7.53 - $14.93 $215,644 - $427,565	28,638 Added 13.16%	246,330 $3.59 Million
Q1 2020 May 06, 2020	BUY	$5.69 - $17.78 $33,548 - $104,830	5,896 Added 2.78%	217,692 $1.85 Million
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $91,552 - $141,153	-8,407 Reduced 3.82%	211,796 $3.49 Million
Q3 2019 Nov 07, 2019	BUY	$12.03 - $19.94 $321,790 - $533,375	26,749 Added 13.83%	220,203 $3.11 Million
Q2 2019 Aug 12, 2019	BUY	$19.05 - $41.04 $170,326 - $366,938	8,941 Added 4.85%	193,454 $3.89 Million
Q1 2019 May 14, 2019	SELL	$28.4 - $41.74 $33,142 - $48,710	-1,167 Reduced 0.63%	184,513 $7.34 Million
Q4 2018 Feb 11, 2019	BUY	$30.9 - $42.97 $190,807 - $265,339	6,175 Added 3.44%	185,680 $6.45 Million
Q3 2018 Nov 09, 2018	BUY	$35.05 - $43.5 $30,248 - $37,540	863 Added 0.48%	179,505 $0
Q2 2018 Aug 06, 2018	BUY	$35.15 - $51.45 $227,033 - $332,315	6,459 Added 3.75%	178,642 $6.57 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $773,028 - $2.08 Million	42,946 Added 33.23%	172,183 $6.72 Million
Q4 2017 Feb 09, 2018	BUY	$13.2 - $18.1 $1.71 Million - $2.34 Million	129,237	129,237 $2.34 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account